| Kerrin D Burte, MD | |
|
2616 Legends Way, Crestview Hills, KY 41017-2418 | |
| (859) 331-3100 | |
| (859) 331-9147 |
| Full Name | Kerrin D Burte |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 39 Years |
| Location | 2616 Legends Way, Crestview Hills, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336144567 | NPI | - | NPPES |
| 660000297 | Other | KY | RR MEDICARE |
| 64271075 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 27107 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Elizabeth Edgewood | Edgewood, KY | Hospital |
| St Elizabeth Florence | Florence, KY | Hospital |
| St Elizabeth Grant | Williamstown, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tristate Arthritis And Rheumatology Psc | 6901858364 | 9 |
News Archive
A new paper by researchers from the USA and China and published on the preprint server bioRxiv in July 2020 discusses a new drug based on the catalase enzyme, which could play a vital part in reducing the inflammation associated with progressive and severe COVID-19 disease.
Mesothelin expression is a significant predictor for tumor aggression in patients with lung adenocarcinoma, suggest study findings published in Clinical Cancer Research.
The latest investigation into a promising new genetic test for glaucoma - the leading cause of blindness worldwide - has found it has the ability to identify 15 times more people at high risk of glaucoma than an existing genetic test.
Administering medications through the nose as an alternative to injections or IVs is becoming increasingly popular in emergency departments and ambulances, according to a paper by Loyola Medicine pharmacists.
› Verified 1 days ago
| Entity Name | Tristate Arthritis & Rheumatology Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851449425 PECOS PAC ID: 6901858364 Enrollment ID: O20050214000539 |
News Archive
A new paper by researchers from the USA and China and published on the preprint server bioRxiv in July 2020 discusses a new drug based on the catalase enzyme, which could play a vital part in reducing the inflammation associated with progressive and severe COVID-19 disease.
Mesothelin expression is a significant predictor for tumor aggression in patients with lung adenocarcinoma, suggest study findings published in Clinical Cancer Research.
The latest investigation into a promising new genetic test for glaucoma - the leading cause of blindness worldwide - has found it has the ability to identify 15 times more people at high risk of glaucoma than an existing genetic test.
Administering medications through the nose as an alternative to injections or IVs is becoming increasingly popular in emergency departments and ambulances, according to a paper by Loyola Medicine pharmacists.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kerrin D Burte, MD 2616 Legends Way, Crestview Hills, KY 41017-2418 Ph: (859) 331-3100 | Kerrin D Burte, MD 2616 Legends Way, Crestview Hills, KY 41017-2418 Ph: (859) 331-3100 |
News Archive
A new paper by researchers from the USA and China and published on the preprint server bioRxiv in July 2020 discusses a new drug based on the catalase enzyme, which could play a vital part in reducing the inflammation associated with progressive and severe COVID-19 disease.
Mesothelin expression is a significant predictor for tumor aggression in patients with lung adenocarcinoma, suggest study findings published in Clinical Cancer Research.
The latest investigation into a promising new genetic test for glaucoma - the leading cause of blindness worldwide - has found it has the ability to identify 15 times more people at high risk of glaucoma than an existing genetic test.
Administering medications through the nose as an alternative to injections or IVs is becoming increasingly popular in emergency departments and ambulances, according to a paper by Loyola Medicine pharmacists.
› Verified 1 days ago
Srilakshmi Mukalla, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 334 Thomas More Pkwy, Crestview Hills, KY 41017 Phone: 859-341-0288 Fax: 859-341-7482 | |
Jon Raymond Minzner, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2765 Chapel Pl, Suite 200, Crestview Hills, KY 41017 Phone: 859-578-3400 Fax: 859-957-0055 | |
Nneka Udechukwu, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 651 Centre View Blvd, Crestview Hills, KY 41017 Phone: 859-371-3376 Fax: 859-331-1053 | |
Dr. Michael E Jones, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 425 Centre View Blvd, Crestview Hills, KY 41017 Phone: 859-341-3575 Fax: 859-341-5701 | |
Dr. Julie Jordan, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2900 Chancellor Dr, Crestview Hills, KY 41017 Phone: 859-341-0288 Fax: 859-363-2140 | |
Mazen Elyan, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 651 Centre View Boulevard, Crestview Hills, KY 41017 Phone: 859-344-1900 Fax: 859-344-4632 | |
Neil D B Desoyza, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 380 Centre View Blvd, Crestview Hills, KY 41017 Phone: 859-341-3015 Fax: 859-341-3215 |